Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: Claud B who wrote (2402)	2/18/1998 6:27:00 PM
From: Bill Wexler	Read Replies (1) \| Respond to of 7041

Zonagen is a fraud, and the stock price will soon reflect that. Zonagen's management has never delivered any meaningful revenues or earnings in the entire history of the company. The current grossly overinflated stock price represents speculation that the company's Vasomax will be approved for the treatment of ED. Zonagen has fraudulently misrepresented this drug by paying various stock promoters and shills to write false, and misleading research reports. These shills were paid with cheap stock which they have unloaded on small investors paying much higher prices. Zonagen's management has a history of similar criminal behavior. They have already tried to patent another drug - Immumax knowing full well that a previous patent was already in existence for the exact same compound. Even after the patent was declined, the company tried to sell the drug. Zonagen has no real research facilities. Vasomax is simply a scheme to defraud investors out of money. Zonagen's stock will eventually crumble...despite the lies and counter-claims by various individuals on Silcon Investor and Yahoo message boards.